Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07823140
What this trial is testing

Effects of Kudzu Root (Gegen) on Drug-Metabolizing Enzymes and Blood Clotting in Healthy Volunteers

Who this might be right for
Herb-drug Interactions
Chinese University of Hong Kong 56
Not applicableStudy completedNCT01582217
What this trial is testing

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

Who this might be right for
Percutaneous Coronary InterventionDual Antiplatelet TherapyAspirin+1 more
Icahn School of Medicine at Mount Sinai 318
Not applicableUnknownNCT02148978
What this trial is testing

Cystic Fibrosis Related Diabetes

Who this might be right for
Cystic Fibrosis
Ram Weiss 30
Early research (Phase 1)Study completedNCT02887443
What this trial is testing

Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate

Who this might be right for
Drug-Drug Interaction
Santhera Pharmaceuticals 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781449
What this trial is testing

Topical JAK-Inhibition of Early-Stage CTCL

Who this might be right for
Mycosis FungoidesCutaneous T-cell Lymphoma
Aarhus University Hospital 15
Not applicableStudy completedNCT02928042
What this trial is testing

Inhibition Effects of Probiotics on Pathogens Associated With VAP

Who this might be right for
Ventilator Associated Pneumonia
Cukurova University 80
Not applicableStudy completedNCT07694102
What this trial is testing

Effect of Integrated Neuromuscular Inhibition Technique on Patients With Non-Specific Neck Pain

Who this might be right for
Non-specific Mechanical Neck Pain
Ibadat International University, Islamabad 42
Large-scale testing (Phase 3)Study completedNCT02044146
What this trial is testing

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary Intervention
Ottawa Heart Institute Research Corporation 120
Not applicableStudy completedNCT03018262
What this trial is testing

Neurophysiology of Surround Inhibition in the Human Motor Cortex

Who this might be right for
Normal Physiology
National Institute of Neurological Disorders and Stroke (NINDS) 53
Large-scale testing (Phase 3)Ended earlyNCT04689594
What this trial is testing

Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

Who this might be right for
Superficial Esophageal Cancer
CellSeed Inc. 1
Not applicableLooking for participantsNCT06510894
What this trial is testing

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

Who this might be right for
Cardiac Sarcoidosis
University of Pennsylvania 40
Large-scale testing (Phase 3)UnknownNCT04277702
What this trial is testing

Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial DiseasePeripheral Vascular DiseasesLower Limb Ischemia+1 more
Jagiellonian University 200
Not applicableLooking for participantsNCT06959342
What this trial is testing

Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder

Who this might be right for
Alcohol Use DisorderSubstance Use Disorders
Central Institute of Mental Health, Mannheim 162
Testing effectiveness (Phase 2)Looking for participantsNCT07392242
What this trial is testing

The Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT01707459
What this trial is testing

The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery

Who this might be right for
Thrombosis
University Health Network, Toronto 201
Testing effectiveness (Phase 2)Ended earlyNCT02317549
What this trial is testing

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148

Who this might be right for
Septic Shock
Leading BioSciences, Inc 8
Testing effectiveness (Phase 2)Study completedNCT00269048
What this trial is testing

SB-480848 In Subjects With Coronary Heart Disease

Who this might be right for
Atherosclerosis
GlaxoSmithKline 969
Testing effectiveness (Phase 2)Looking for participantsNCT07409103
What this trial is testing

Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Who this might be right for
Active Rheumatoid Arthritis
Elevara Medicines Limited 180
Not applicableStudy completedNCT03368703
What this trial is testing

Physiopathology of Lower Cortical Activation in COPD Patients: Contribution of Cortical Neuromodulation

Who this might be right for
Physiology
5 Santé 34
Not applicableStudy completedNCT01925794
What this trial is testing

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Who this might be right for
Coronary Artery Disease
CeloNova BioSciences, Inc. 296
Next Page